ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,055Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 978

$1.18M Total Retail Price of All Prescriptions

Rank: 4 out of 978

452 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 20,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,818 1,749 1 11
SIMVASTATIN 912 888 2 2
LEVOTHYROXINE SODIUM 897 897 3 4
METOPROLOL TARTRATE 682 674 4 10
DONEPEZIL HCL 659 659 5 26
NAMENDA 637 632 6 45
LISINOPRIL 636 602 7 1
MIRTAZAPINE 551 551 8 31
FUROSEMIDE 549 545 9 9
AMLODIPINE BESYLATE 544 544 10 6
TRAZODONE HCL 527 523 11 18
CITALOPRAM HBR 491 481 12 14
RISPERIDONE 364 318 13 49
SERTRALINE HCL 347 347 14 21
OMEPRAZOLE 316 316 15 3
QUETIAPINE FUMARATE 299 299 16 51
POTASSIUM CHLORIDE 291 280 17 41
GABAPENTIN 269 252 18 15
LANTUS 228 212 19 40
DIVALPROEX SODIUM 211 210 20 56
LIDODERM 201 194 21 65
CYMBALTA 199 199 22 60
ATENOLOL 189 189 23 8
METOPROLOL SUCCINATE 185 172 24 13
GLIPIZIDE 180 180 25 50
ABILIFY 158 158 26 106
CARVEDILOL 147 135 27 55
OLANZAPINE 144 144 28 75
ISOSORBIDE MONONITRATE ER 142 142 29 57
HYDROCHLOROTHIAZIDE 136 125 30 5
METFORMIN HCL 134 125 31 7
SPIRIVA 131 131 32 37
DIGOXIN 130 130 33 54
PREDNISONE 127 127 34 47
NOVOLIN N 126 125 35 228
HYDRALAZINE HCL 125 125 36 139
RANITIDINE HCL 121 121 37 27
TRAMADOL HCL 120 117 38 24
HYDROCODONE-ACETAMINOPHEN 114 114 S3 39 17
SEROQUEL 111 111 40 113
ATORVASTATIN CALCIUM 103 103 41 12
LEVETIRACETAM 95 95 42 93
GALANTAMINE HBR 94 94 43 149
DILTIAZEM 24HR CD 92 87 44 111
ESCITALOPRAM OXALATE 90 77 45 117
HUMALOG 90 90 45 129
MORPHINE SULFATE 88 87 S2 47 163
ALENDRONATE SODIUM 87 87 48 20
OXYBUTYNIN CHLORIDE ER 85 72 49 99
CLOPIDOGREL 85 85 49 61
CARBIDOPA-LEVODOPA 83 83 51 81
CARBAMAZEPINE 82 59 52 128
NOVOLOG 80 68 53 121
NIFEDIPINE ER 77 77 54 70
ALLOPURINOL 73 73 55 34
ERYTHROMYCIN 73 71 55 188
CIPROFLOXACIN HCL 72 72 57 105
VANCOMYCIN HCL 70 70 58 290
LOSARTAN POTASSIUM 70 70 58 22
PLAVIX 69 69 60 96
BRIMONIDINE TARTRATE 69 69 60 245
TAMSULOSIN HCL 69 69 60 33
RESTASIS 68 68 63 296
LEVOFLOXACIN 68 66 63 98
PAROXETINE HCL 67 67 65 52
FENTANYL 63 63 S2 66 85
PANTOPRAZOLE SODIUM 63 63 66 39
NYSTATIN 61 61 68 126
PHENYTOIN SODIUM EXTENDED 60 44 69 147
DOXYCYCLINE HYCLATE 60 60 69 146
AVELOX 60 60 69 311
LANSOPRAZOLE 59 59 72 259
DIVALPROEX SODIUM ER 56 44 73 210
NYSTOP 56 56 73 118
OXYCODONE HCL 55 54 S2 75 23
LATANOPROST 55 55 75 163
NITROFURANTOIN MONO-MACRO 54 53 77 171
ADVAIR DISKUS 54 54 77 35
FLUTICASONE PROPIONATE 54 52 77 28
TRIAMCINOLONE ACETONIDE 53 52 80 136
CEPHALEXIN 53 53 80 131
TIMOLOL MALEATE 53 53 80 223
DORZOLAMIDE HCL 52 52 83 332
BUMETANIDE 50 50 84 190
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.